BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11596461)

  • 1. [Myopathies with miscellaneous disorders related to mitochondrial fatty acid oxidation: defective synthesis of ketone body, long-chain fatty acid transport defect, and muscular coenzyme Q10 deficiency].
    Takusa Y; Yamaguchi S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):90-4. PubMed ID: 11596461
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mitochondrial beta-oxidation defects].
    Woldseth B; Rootwelt T
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):756-9. PubMed ID: 16541168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of impairment of mitochondrial fatty acid beta-oxidation.
    Hasegawa T; Hori N; Du W
    Keio J Med; 2002 Jun; 51(2):100-6. PubMed ID: 12125906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mitochondrial beta-oxidation defects: overview].
    Yamaguchi S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):60-4. PubMed ID: 11596451
    [No Abstract]   [Full Text] [Related]  

  • 5. The diagnosis of mitochondrial HMG-CoA synthase deficiency.
    Zschocke J; Penzien JM; Bielen R; Casals N; Aledo R; Pié J; Hoffmann GF; Hegardt FG; Mayatepek E
    J Pediatr; 2002 Jun; 140(6):778-80. PubMed ID: 12072887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women.
    Holloway GP; Thrush AB; Heigenhauser GJ; Tandon NN; Dyck DJ; Bonen A; Spriet LL
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1782-9. PubMed ID: 17311893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myopathies caused by disorders of lipid metabolism.
    Carroll JE
    Neurol Clin; 1988 Aug; 6(3):563-74. PubMed ID: 3065601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coenzyme Q10 deficiency].
    Imataka G; Yamanouchi H
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():462-5. PubMed ID: 12013914
    [No Abstract]   [Full Text] [Related]  

  • 9. Inborn errors of mitochondrial fatty acid oxidation.
    Bennett MJ; Rinaldo P; Strauss AW
    Crit Rev Clin Lab Sci; 2000 Feb; 37(1):1-44. PubMed ID: 10737439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview.
    Holloway GP; Luiken JJ; Glatz JF; Spriet LL; Bonen A
    Acta Physiol (Oxf); 2008 Dec; 194(4):293-309. PubMed ID: 18510711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in long chain fatty acid oxidation presenting as severe cardiomyopathy and cardiogenic shock in infancy.
    Dereddy NR; Kronn D; Krishnan U
    Cardiol Young; 2009 Sep; 19(5):540-2. PubMed ID: 19691901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of the pyruvate dehydrogenase complex and of mitochondrial fatty acid oxidation.
    Bindoff LA; Birch-Machin MA; Jackson S; Singh Kler R; Bartlett K; Turnbull DM
    Rev Neurol (Paris); 1991; 147(6-7):526-31. PubMed ID: 1962058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic evaluation of muscle coenzyme Q10 content in children with mitochondrial respiratory chain enzyme deficiencies.
    Miles MV; Miles L; Tang PH; Horn PS; Steele PE; DeGrauw AJ; Wong BL; Bove KE
    Mitochondrion; 2008 Mar; 8(2):170-80. PubMed ID: 18313367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency.
    Lalani SR; Vladutiu GD; Plunkett K; Lotze TE; Adesina AM; Scaglia F
    Arch Neurol; 2005 Feb; 62(2):317-20. PubMed ID: 15710863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial fatty acid oxidation disorders in Thai infants: a report of 3 cases.
    Wasant P; Matsumoto I; Naylor E; Liammongkolkul S
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S710-9. PubMed ID: 12403251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defects in mitochondrial fatty acid oxidation: clinical presentations and their role in sudden infant death.
    Pollitt RJ
    Padiatr Padol; 1993; 28(1):13-7. PubMed ID: 8446423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial fatty-acid oxidation disorders.
    Kompare M; Rizzo WB
    Semin Pediatr Neurol; 2008 Sep; 15(3):140-9. PubMed ID: 18708005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ubiquinone: metabolism and functions. Ubiquinone deficiency and its implication in mitochondrial encephalopathies. Treatment with ubiquinone].
    Artuch R; Colomé C; Vilaseca MA; Pineda M; Campistol J
    Rev Neurol; 1999 Jul 1-15; 29(1):59-63. PubMed ID: 10528314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of impaired ketogenesis in fatty acid oxidation disorders.
    Olpin SE
    Prostaglandins Leukot Essent Fatty Acids; 2004 Mar; 70(3):293-308. PubMed ID: 14769488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inborn errors of ketogenesis.
    Mitchell GA; Wang SP; Ashmarina L; Robert MF; Bouchard G; Laurin N; Kassovska-Bratinova S; Boukaftane Y
    Biochem Soc Trans; 1998 May; 26(2):136-40. PubMed ID: 9649735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.